These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1688954)

  • 1. Classification of sexual dysfunction for management of intracavernous medication-induced erections.
    Fein RL
    J Urol; 1990 Feb; 143(2):298-301. PubMed ID: 1688954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
    Zorgniotti AW; Lefleur RS
    J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
    Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI
    J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation.
    Hadzija BW; Mattocks AM; Stahl GM
    J Urol; 1988 Jul; 140(1):64-5. PubMed ID: 2454330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
    Hu KN; Burks C; Christy WC
    J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury.
    Sidi AA; Cameron JS; Dykstra DD; Reinberg Y; Lange PH
    J Urol; 1987 Sep; 138(3):539-42. PubMed ID: 2442418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernous self-injection for erectile failure.
    Ruutu M; Lindström BL; Virtanen J; Alfthan O
    Eur Urol; 1988; 15(1-2):96-8. PubMed ID: 3215245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
    Kiely EA; Bloom SR; Williams G
    Br J Urol; 1989 Aug; 64(2):191-4. PubMed ID: 2765789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device.
    Montorsi F; Guazzoni G; Bergamaschi F; Orlandini A; Da Pozzo L; Barbieri L; Rigatti P
    J Urol; 1993 Dec; 150(6):1829-32. PubMed ID: 7693979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
    Lloyd LK; Richards JS
    Paraplegia; 1989 Dec; 27(6):457-64. PubMed ID: 2608299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S; Shalev M; Nissenkorn I
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
    Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P
    J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.